Korean J Endocr Surg.
2004 Jun;4(1):1-9. 10.16956/kjes.2004.4.1.1.
Regulation of Sodium-iodine Symporter Expression by Retinoic Acid in Thyroid Cancer Cell Lines
- Affiliations
-
- 1Center for Breast Cancer, National Cancer Center, Korea.
- 2Clinical Research Institute, Seoul National University Hospital, Korea. ykyoun@plaza.snu.ac.kr
- 3Department of Surgery, Chungbuk National University College of Medicine, Korea.
- 4Department of Surgery, University of California, San Francisco, Mt. Zion Medical Center, San Francisco, USA.
- 5Department of Surgery, Seoul National University College of Medicine, Korea.
- KMID: 2376119
- DOI: http://doi.org/10.16956/kjes.2004.4.1.1
Abstract
- PURPOSE
Response to radioiodine therapy for thyroid cancer is related to the loss of sodium-iodine symporter protein caused by dedifferentiation of thyroid cancer cells. So we aimed to study mRNA expression of CD97, dedifferentiation marker, and sodium-iodine symporter after retinoic acid treatment according to retinoids receptor status.
METHODS
Thyroid cancer cell lines; ARO, FRO, NPA, TPO, and FTC133 were prepared. 5µM of all trans retinoic acid were administered to each cell lines and then expression of m RNA for retinoids receptors (RARα, RARβ, RARγ, RXRα, RXRβ, RXRγ), CD97, and Sodium-Iodine symporter by RT-PCR.
RESULTS
RARs and RXRs were differently expressed in each cell line. After retinoic acid treatment, relative density of retinoic acid receptor mRNA were increased by time dependently in each cell line except TPO cell line. Expression of CD97 also was decreased in every cell lines (P<0.001). Retinoic acid increased expression of sodium-iodine symporter only in FTC133 cell line (P<0.001), and TSH or forskolin did not enhance NIS expression by retinoic acid. RARβ and RXRγ were expressed only in FTC 133cell line before treatment. Induction of sodium-iodine symporter by retinoids disappeared after RARβ specific antagonist LE135 or pan RXR antagonist PA452 administration.
CONCLUSION
Retinoic acid reduced expression of CD97 in five thyroid cancer cell lines. However, retinoic acid could restore sodium-iodine symporter expression in only FTC 133 cell line specifically containing RARβ and RXRγ. Restoration of sodium-iodine symporter expression by retinoic acid is related to RARβ and RXRγ expression.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Sodium Iodide Symporter (NIS) in the Management of Patients with Thyroid Carcinoma
- Alpha-Lipoic Acid Decreases Iodine Uptake in the Rat Thyroid Cell Line FRTL-5
- Effects of alpha-lipoic Acid on Differentiation of Thyroid Cancer Cells
- Expression of Human Sodium Iodide Symporter mRNA in Papillary Thyroid Carcinoma
- Radioactive Iodine-Refractory Differentiated Thyroid Cancer and Redifferentiation Therapy
